Breast cancer genetic tests have improved and doctors urge retesting

Over the past decade, the phrases โ€˜BRCA 1โ€™ and โ€˜BRCA 2โ€™ went mainstream as genetic testing to assess breast cancer risk became common.

But, now, doctors are telling patients whose tests were negative to get retested.

โ€œI think this is a game changer,โ€ said Peter Beitsch, MD, a breast cancer specialist at Medical City Hospital in Dallas. โ€œThe BRCA 1 and 2 testing was a game changer. This now goes from testing two genes to testing 18 genes. This is big.โ€

Read the full, original story:ย Doctors Recommend Genetic Retesting For Breastย Cancer

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesnโ€™t change the scienceโ€”the worldโ€™s most popular herbicide is safeย 
ChatGPT-Image-Apr-16-2026-02_56_53-PM
Financial incentives, over diagnosis, and weak oversight: Autism claims are driving up Medicare costs
Picture1
The FDA couldnโ€™t find a vaccine safety crisis, so it buried its own research
global warming
โ€˜Implausibleโ€™: Top climate scientists reject worst-case scenarioโ€”soaring temperatures and fast-rising sea levels
ChatGPT-Image-May-1-2026-11_42_59-AM-2
Viewpoint: NAD is the wellness grifters latest evidence-lite longevity fad. At least the mice are impressed.

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.